REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 122 filers reported holding REVANCE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,624,000 | +10.8% | 65,366 | +22.4% | 0.01% | +10.0% |
Q2 2018 | $1,466,000 | -0.8% | 53,414 | +11.3% | 0.01% | -16.7% |
Q1 2018 | $1,478,000 | +20.7% | 47,981 | +40.0% | 0.01% | +50.0% |
Q4 2017 | $1,225,000 | +46.5% | 34,279 | +12.9% | 0.01% | +33.3% |
Q3 2017 | $836,000 | +16.0% | 30,351 | +11.1% | 0.01% | +20.0% |
Q2 2017 | $721,000 | +41.4% | 27,324 | +11.4% | 0.01% | +25.0% |
Q1 2017 | $510,000 | -10.1% | 24,531 | -10.5% | 0.00% | 0.0% |
Q4 2016 | $567,000 | -3.7% | 27,404 | -24.5% | 0.00% | -20.0% |
Q3 2016 | $589,000 | +8.3% | 36,313 | -9.2% | 0.01% | 0.0% |
Q2 2016 | $544,000 | -1.3% | 39,990 | +26.7% | 0.01% | -16.7% |
Q1 2016 | $551,000 | -56.4% | 31,559 | -14.6% | 0.01% | -50.0% |
Q4 2015 | $1,263,000 | -88.7% | 36,968 | -1.4% | 0.01% | 0.0% |
Q3 2015 | $11,154,000 | +1369.6% | 37,481 | +57.9% | 0.01% | +100.0% |
Q2 2015 | $759,000 | +211.1% | 23,738 | +101.4% | 0.01% | +200.0% |
Q1 2015 | $244,000 | – | 11,784 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |